Quantcast

Latest Prostate-specific antigen Stories

2014-10-27 12:30:42

Task Force says harms of PSA screening outweigh the benefits OTTAWA, Oct.

2014-10-22 08:27:56

NEW YORK, Oct.

2014-09-29 08:31:04

Strongly Positive Results, Presented at European Society for Medical Oncology (ESMO) 2014 Congress, Demonstrated Oncotype DX® Prostate Cancer Test was an Independent Predictor of Tumor Aggressiveness REDWOOD

2014-09-29 08:29:46

Final data after 49-month follow-up analysis in chemotherapy-naïve men with metastatic castration-resistant prostate cancer presented at European Society for Medical Oncology (ESMO) 2014 Congress

2014-09-28 08:21:14

Final analysis of Phase 3 COU-AA-302 study presented at the European Society for Medical Oncology (ESMO) 2014 Congress HORSHAM, Pa., Sept.

2014-09-22 08:27:42

-- Free Or Low Cost Screenings Help To Diagnose Second Leading Cause of Death Among Men Which Can Be Easily Treated If Caught Early -- DENVER, Sept.

2014-09-18 08:29:25

Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept.

2014-09-17 08:30:32

Proprietary genomic-based VPAC1 cancer biomarker to be co-developed worldwide? PARK CITY, Utah, Sept. 17, 2014 /PRNewswire/ -- NuView Life Sciences, Inc.